COMMUNIQUÉS West-GlobeNewswire

OncBioMune Phase 2 Clinical Trial to Begin Enrollment; Company Announces Other Developments and Corporate Milestones
08/11/2018
BATON ROUGE, La., Nov. 08, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Sienna Biopharmaceuticals® Reports Third Quarter 2018 Financial Results
08/11/2018
WESTLAKE VILLAGE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today reported the Company’s financial results for [...]
RAMSAY GENERALE DE SANTE : Final outcome OPA Capio
08/11/2018
PRESS RELEASE THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRICA. THE OFFER HAS NOT BEEN MADE TO (AND ACCEPTANCES [...]
RAMSAY GENERALE DE SANTE contrôle 98,51% du capital de Capio à l'issue de la période d'acceptation prolongée
08/11/2018
COMMUNIQUE DE PRESSE LE PRESENT COMMUNIQUE DE PRESSE NE PEUT ETRE, DIRECTEMENT OU INDIRECTEMENT, DISTRIBUE OU PUBLIE EN AUSTRALIE, CANADA, HONG KONG, JAPON, NOUVELLE ZELANDE, OU AFRIQUE DU SUD. L'OFFRE N'A PAS ETE FAITE [...]
Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results
08/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]
Cabaletta Bio Emerges Out of University of Pennsylvania to Develop CAAR T Cell Technology to Treat B Cell-mediated Autoimmune Diseases
08/11/2018
-- Signs exclusive license agreement and multi-year sponsored research agreements with University of Pennsylvania -- C ompletes $38 million Series A financing to advance lead asset, DSG3-CAART for mucosal pemphigus [...]
CohBar Co-Founder and Scientific Advisor Dr. David Sinclair Named as one of TIME Magazine’s Health Care 50
08/11/2018
Cited for his groundbreaking work on the underlying metabolic causes of aging MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference
08/11/2018
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases [...]
Genmab to Present at the Jefferies 2018 London Healthcare Conference
08/11/2018
Media Release Copenhagen, Denmark; November 8, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company’s CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 2018 London Healthcare [...]
Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update
08/11/2018
- New Aegerion loan facility, provided by existing bondholders, strengthens balance sheet and is expected to provide bridge to a potential comprehensive long-term capital restructuring - Company expects to achieve [...]
SELLAS Life Sciences to Provide Third Quarter 2018 Financial Results and Corporate Update on November 15, 2018
08/11/2018
NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Homology Medicines to Present at Stifel Healthcare Conference
08/11/2018
BEDFORD, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will present during a fireside chat at the Stifel [...]
Albireo to Present at Investor Conferences in November
08/11/2018
BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018
08/11/2018
MINNEAPOLIS, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Acer Therapeutics to Present at the Evercore ISI HealthConX Conference
08/11/2018
NEWTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
48North Cannabis Corp. Acquires Good & Green for Next Generation Cannabis Products -- CFN Media
08/11/2018
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Insmed Announces Changes to its Board of Directors
08/11/2018
—Seasoned Pharmaceutical Executive Elizabeth McKee Anderson Appointed as New Director— —Donald Hayden, Jr. Steps Down as Chairman After 13 Years of Distinguished Service— —Chief Executive Officer Will Lewis Elected [...]
Tabula Rasa HealthCare Acquires Cognify an Integration HealthCare Technology Company
08/11/2018
Delivering optimal business performance and outcomes through integrated technology services to senior care organizations and PACE MOORESTOWN, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ [...]
Misonix to Participate in Three Upcoming Investor Conferences
08/11/2018
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Pages